3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Non-Hodgkin
11
Lymphoma, Mantle-Cell
11
Lymphoma, Follicular
11
Leukemia, Lymphocytic, Chronic, B-Cell
10
Lymphoma
9
Lymphoma, B-Cell, Marginal Zone
5
Recurrence
4
Lymphoma, B-Cell
4
Leukemia, Hairy Cell
4
Burkitt Lymphoma
4
Waldenstrom Macroglobulinemia
3
Neoplasms
3
Leukemia
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Leukemia, B-Cell
2
Epstein-Barr Virus Infections
2
beta-Thalassemia
1
Thalassemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphatic Diseases
1
Lymphadenopathy
1
Leukemia, Prolymphocytic
1
Interventions
Cytarabine
5
Whole-Body Irradiation
4
fludarabine
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Cyclophosphamide
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
nilotinib
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
asciminib
2
Tacrolimus
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Rituximab
×
30 days
×
Clear all
No trials found.